These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
107 related articles for article (PubMed ID: 3037416)
1. Differential tolerance to repeated daily injections of N-allylnormetazocine and its enantiomers in the rat. Young GA; Hong O; Khazan N Neuropharmacology; 1987 May; 26(5):463-7. PubMed ID: 3037416 [TBL] [Abstract][Full Text] [Related]
2. Sigma receptors mediated the psychotomimetic effects of N-allylnormetazocine (SKF-10,047), but not its opioid agonistic-antagonistic properties. Khazan N; Young GA; El-Fakany EE; Hong O; Calligaro D Neuropharmacology; 1984 Aug; 23(8):983-7. PubMed ID: 6090969 [TBL] [Abstract][Full Text] [Related]
3. Differential tolerance and cross-tolerance to repeated daily injections of mu and kappa opioid agonists in the rat. Young GA; Khazan N Neuropharmacology; 1984 May; 23(5):505-9. PubMed ID: 6330605 [TBL] [Abstract][Full Text] [Related]
4. Differential neuropharmacological effects of mu, kappa and sigma opioid agonists on cortical EEG power spectra in the rat. Stereospecificity and naloxone antagonism. Young GA; Khazan N Neuropharmacology; 1984 Oct; 23(10):1161-5. PubMed ID: 6097833 [TBL] [Abstract][Full Text] [Related]
5. Sigma opioid receptors; SKF-10,047 update. Khazan N; Young GA; el-Fakahany EE; Hong O; Calligaro D Neuropeptides; 1985 Feb; 5(4-6):339-40. PubMed ID: 2987734 [TBL] [Abstract][Full Text] [Related]
6. Modulation of morphine-induced EEG and behavioral effects by dynorphin A-(1-13) in non-tolerant and morphine-tolerant rats. Hong O; Young GA; Khazan N Neuropharmacology; 1988 Aug; 27(8):807-12. PubMed ID: 2905786 [TBL] [Abstract][Full Text] [Related]
7. Dissociation of naloxone-sensitive and naloxone-insensitive effects of U-50,488H. Young GA Pharmacol Biochem Behav; 1989 May; 33(1):215-7. PubMed ID: 2780779 [TBL] [Abstract][Full Text] [Related]
8. Non-opioid psychotomimetic-like discriminative stimulus properties of N-allylnormetazocine (SKF 10,047) in the rat. Shearman GT; Herz A Eur J Pharmacol; 1982 Aug; 82(3-4):167-72. PubMed ID: 6290235 [TBL] [Abstract][Full Text] [Related]
9. Electroencephalographic (EEG), EEG power spectra, and behavioral correlates in rats given phencyclidine. Mattia A; Moreton JE Neuropharmacology; 1986 Jul; 25(7):763-9. PubMed ID: 3748323 [TBL] [Abstract][Full Text] [Related]
10. Comparative electroencephalographic and behavioral effects of phencyclidine, (+)-SKF-10,047 and MK-801 in rats. Marquis KL; Paquette NC; Gussio RP; Moreton JE J Pharmacol Exp Ther; 1989 Dec; 251(3):1104-12. PubMed ID: 2557412 [TBL] [Abstract][Full Text] [Related]
11. Effects of SKF-10047 in the phencyclidine-dependent rat: evidence for common receptor mechanisms. Stafford I; Tomie A; Wagner GC Drug Alcohol Depend; 1983 Oct; 12(2):151-6. PubMed ID: 6317323 [TBL] [Abstract][Full Text] [Related]
12. Stereoisomers of N-allylnormetazocine: phencyclidine-like behavioral effects in squirrel monkeys and rats. Brady KT; Balster RL; May EL Science; 1982 Jan; 215(4529):178-80. PubMed ID: 6274022 [TBL] [Abstract][Full Text] [Related]
13. Electroencephalographic and behavioral effects of D-ala2-methionine-enkephalinamide and morphine in the rat. Tortella FC; Moreton JE; Khazan N J Pharmacol Exp Ther; 1978 Sep; 206(3):636-43. PubMed ID: 702326 [TBL] [Abstract][Full Text] [Related]
14. Phencyclidine-induced stereotyped behaviors after injection of morphine and N-allylnormetazocine (SKF 10,047) in rats. Nabeshima T; Hiramatsu M; Kameyama T Pharmacol Biochem Behav; 1986 Jun; 24(6):1629-34. PubMed ID: 3016758 [TBL] [Abstract][Full Text] [Related]
15. Electroencephalographic studies on the development of tolerance and cross tolerance to mescaline in the rat. Colasanti B; Khazan N Psychopharmacologia; 1975 Sep; 43(3):201-5. PubMed ID: 171694 [TBL] [Abstract][Full Text] [Related]
16. Naltrindole retards tolerance development to morphine-induced effects on EEG and EEG power spectra. Stamidis H; Young GA Eur J Pharmacol; 1992 Mar; 213(1):9-16. PubMed ID: 1499659 [TBL] [Abstract][Full Text] [Related]
17. Effects of acute and chronic administration of (+)-SKF 10,047 on body temperature in the rat: cross-sensitization with phencyclidine. Bejanian M; Pechnick RN; George R J Pharmacol Exp Ther; 1990 Jun; 253(3):1253-8. PubMed ID: 2162950 [TBL] [Abstract][Full Text] [Related]
18. Actions of centrally administered neuropeptide Y on EEG activity in different rat strains and in different phases of their circadian cycle. Zini I; Merlo Pich E; Fuxe K; Lenzi PL; Agnati LF; Härfstrand A; Mutt V; Tatemoto K; Moscara M Acta Physiol Scand; 1984 Sep; 122(1):71-7. PubMed ID: 6548858 [TBL] [Abstract][Full Text] [Related]
19. [Specific binding of N-allylnormetazocine (SKF 10047), a ligand of sigma-opioid receptors, with liver membranes]. Samovilova NN; Iarygin KN; Vinogradov VA Bioorg Khim; 1985 Oct; 11(10):1380-4. PubMed ID: 3000388 [TBL] [Abstract][Full Text] [Related]
20. Different effects of ethylketocyclazocine on phencyclidine- and N-allylnormetazocine-induced stereotyped behaviors in rats. Hiramatsu M; Nabeshima T; Furukawa H; Kameyama T Pharmacol Biochem Behav; 1987 Dec; 28(4):489-94. PubMed ID: 2893389 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]